PETER VIA: Open Payments
NPI 1235441833 · SPRINGFIELD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $496
Food & beverage: $362Education: $134
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $256 |
| TOLMAR, INC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| UROGEN PHARMA, INC. | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Caris MPI, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| Organon LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: ERLEADA, JATENZO, IMFINZI, ORGOVYX, ADSTILADRIN, MI CANCER SEEK, Nubeqa.
Industry payments across OR — which companies pay providers there.
